Effects of boron-containing compounds on immune responses: review and patenting trends
- 4 May 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 29 (5) , 339-351
Abstract
Introduction: Boron-containing compounds induce effects on immune responses. Such effects are interesting to the biomedical field for the development of therapeutic tools to modulate the immune system. Areas covered: The scope of BCC use to modify immune responses is expanding, mainly with regard to inflammatory diseases. The information was organized to demonstrate the breadth of reported effects. BCCs act as modulators of innate and adaptive immunity, with the former including regulation of cluster differentiation and cytokine production. In addition, BCCs exert effects on inflammation induced by infectious and noninfectious agents, and there are also reports regarding their effects on mechanisms involving hypersensitivity and transplants. Finally, the authors discuss the beneficial effects of BCCs on pathologies involving various targets and mechanisms. Expert opinion: Some BCCs are currently used as drugs in humans. The mechanisms by which these BCCs modulate immune responses, as well as the required structure–activity relationship for each observed mechanism of action, should be clarified. The former will allow for the development of improved immunomodulatory drugs with extensive applications in medicine. Patenting trends involve claims concerning the synthesis and actions of identified molecules with a defined profile regarding cytokines, cell differentiation, proliferation, and antibody production.Keywords
Funding Information
- Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional (M1930)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (CB235785)
This publication has 106 references indexed in Scilit:
- Inhibition of Toll-Like Receptor-Mediated Inflammation In Vitro and In Vivo by a Novel BenzoxaboroleThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophilsBioorganic & Medicinal Chemistry, 2012
- Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell MalignanciesClinical Cancer Research, 2011
- The boron-oxygen core of borinate esters is responsible for the store-operated calcium entry potentiation abilityBMC Pharmacology, 2011
- Boron nitride nanotube reinforced polylactide–polycaprolactone copolymer composite: Mechanical properties and cytocompatibility with osteoblasts and macrophages in vitroActa Biomaterialia, 2010
- Effect of dietary boron on immune function in growing beef steers*Journal of Animal Physiology and Animal Nutrition, 2010
- Hydrogel Contact Lens Binding Induced by Contact Lens Rewetting DropsOptometry and Vision Science, 2008
- Membrane-delimited Regulation of Novel Background K+ Channels by MgATP in Murine Immature B CellsJournal of Biological Chemistry, 2004
- Boronate-Containing Polymer as Novel Mitogen for LymphocytesBiochemical and Biophysical Research Communications, 1993
- Anti-Inflammatory Activity of Amine Cyanoboranes, Amine Carboxyboranes, and Related CompoundsJournal of Pharmaceutical Sciences, 1980